Megakaryocytes and platelets in vascular disease

被引:64
|
作者
vanderLoo, B [1 ]
Martin, JF [1 ]
机构
[1] UCL, DEPT MED, BRITISH HEART FDN, LONDON W1P 9LN, ENGLAND
来源
BAILLIERES CLINICAL HAEMATOLOGY | 1997年 / 10卷 / 01期
关键词
platelet; megakaryocyte; atherosclerosis; thrombosis; acute coronary syndromes; myocardial infarction;
D O I
10.1016/S0950-3536(97)80053-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelets are anucleate cells with no DNA. They are derived from their precursor, the megakaryocyte (MK), whose differentiation is characterized by nuclear polyploidization through a process called endomitosis. Changes in the MK-platelet-haemostasis axis may precede acute thrombotic events. Changes in MK ploidy distribution may be associated with the production of large platelets. Mean platelet volume (MPV) is an important biological variable as it is a determinant of platelet reactivity. Large platelets are denser and more active haemostatically. MPV is increased in patients after myocardial infarction (MI) and is a predictor of a further ischaemic event and death when measured after MI. It has been suggested that changes not only in platelets but also in the parental MK are associated with chronic and acute vascular events. The regulation of megakaryocytopoiesis depends on several haematopoietic factors such as thrombopoietin. An understanding of the signalling system that controls platelet number and size might give insight into a role of platelet production in thrombogenesis and atherogenesis.
引用
收藏
页码:109 / 123
页数:15
相关论文
共 50 条
  • [1] MEGAKARYOCYTES AND PLATELETS
    不详
    [J]. LANCET, 1949, 257 (JUL30): : 202 - 203
  • [2] Presence of vascular endothelial growth factor (VEGF) in megakaryocytes and platelets
    Banks, RE
    Forbes, MA
    Stanley, A
    Kinsey, S
    Ingham, E
    Walters, C
    Selby, PJ
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 78 - 78
  • [3] Genomics and transcriptomics of megakaryocytes and platelets: Implications for health and disease
    Fisher, Marlie H.
    Di Paola, Jorge
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2018, 2 (04) : 630 - 639
  • [4] Introduction to a review series: megakaryocytes to platelets in health and disease
    Parise, Leslie V.
    [J]. BLOOD, 2016, 127 (10) : 1215 - 1215
  • [5] Platelets and vascular disease
    Moser, Martin
    Bode, Christoph
    [J]. HAMOSTASEOLOGIE, 2009, 29 (04): : 319 - 319
  • [6] Platelets in vascular disease
    Reinhart, W. H.
    [J]. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2013, 53 (1-2) : 71 - 79
  • [7] The evolution of megakaryocytes to platelets
    Nurden, P
    Poujol, C
    Nurden, AT
    [J]. BAILLIERES CLINICAL HAEMATOLOGY, 1997, 10 (01): : 1 - 27
  • [8] MEGAKARYOCYTES AND BLOOD PLATELETS
    LEVY, F
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1945, 15 (04) : 154 - 158
  • [9] Effects of vascular endothelial growth factors and their receptors on megakaryocytes and platelets and related diseases
    Yang, Jin-Gang
    Wang, Li-Li
    Ma, Dong-Chu
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (03) : 321 - 334
  • [10] PLATELETS, ENDOTHELIUM AND VASCULAR DISEASE
    MUSTARD, JF
    DOWNIE, HG
    ROWSELL, HC
    ROBINSON, GA
    GEISSING.HD
    MURPHY, EA
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 1962, 86 (05) : 228 - &